Given the well-known roles of PTP1B in regulating insulin and leptin signaling, the development of a PTP1B inhibitor for the treatment of diabetes and obesity is already in progress10, 11, 40, 41, 42. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.